FDA Headquarters

FDA Urges Industry to Broaden Clinical Trial Diversity Efforts

Despite concerted policy efforts in recent years, a new U.S. Food and Drug Administration (FDA) draft guidance says “challenges to participation in clinical trials remain, and certain groups continue to be underrepresented in many clinical trials.” The draft guidance, “Enhancing the Diversity of Clinical Trial Populations–Eligibility Criteria, Enrollment Practices, and Trial Designs,” recommends new approaches […]

Syneos Team Forges Winning Bond in All-Star Challenge Victory

Seven years before America landed two men on the moon, President John F. Kennedy challenged the nation by saying “we choose to do [it] not because [it’s] easy, but because [it’s] hard.” And while no one who participated in the recent ACRP All-Star Challenge for Sponsors and CROs is likening it to an Apollo manned […]

Michael D. Watkins, Cofounder, Genesis Advisors

Why Do Some New Leaders Stumble Out of the Starting Gate?

While many clinical trial professionals struggle with the lack of clear career paths in the industry, there are tools, tactics, and best practices to help spot and leverage new opportunities. In this occasional series, we’ll hear from leading experts both in and outside the clinical trial industry as they offer insights on how to thrive […]

Patient Centricity Illustration

Taking the Pulse of Patient Centricity

How long can a healthcare concept be trendy before fully proving itself capable of making the leap into widespread implementation? We may be close to finding out in the case of today’s much-discussed, but still somewhat head-scratching, “patient centricity” focus. In late 2014, contributor Zuzanna Fimińska wrote in an eyeforpharma post that, “[a]lthough it has […]